NHS agrees to fund 'vital' MS drug
Daily Mail - UK
The National Institute for Health and Clinical Excellence will confirm today that patients with a rapidly disabling form of MS can be treated with Tysabri. ...
See all stories on this topic

Biogen Idec, Elan Publish Tysabri Results
FDA news (subscription) - Falls Church,VA,USA
Biogen Idec and Elan announced the publication of results of Phase III studies of Tysabri in the Annals of Neurology, demonstrating that patients with ...
See all stories on this topic